Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
2019
929 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
52.75
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 | Researchclopedia
·
Memorial Sloan Kettering Cancer Center
Peter Hersey
·
The University of Sydney
Richard W. Joseph
·
Mayo Clinic in Florida
Jeffrey S. Weber
·
NYU Langone Health
Roxana Dronca
·
Mayo Clinic in Florida
Tara C. Mitchell
·
University of Pennsylvania
Amita Patnaik
·
South Texas Accelerated Research Therapeutics
Hassane M. Zarour
·
UPMC Hillman Cancer Center
Anthony M. Joshua
·
UNSW Sydney
Qi Zhao
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
E. Jensen
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
S. Ahsan
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Nageatte Ibrahim
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Antoni Ribas
·
University of California, Los Angeles